Reabsorbable Magnesium Scaffold in Clinical Practice: State of the Art and Future Perspectives
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: closed (31 October 2021) | Viewed by 2911
Special Issue Editor
Interests: interventional cardiology; structural cardiology; intravascular imaging; bifurcation; bioresorbable scaffold
Special Issue Information
Dear Colleagues,
Bioresorbable scaffolds (BRS) may represent a step forward in the treatment of coronary artery lesions. The advantages of this device are mainly due to its potential long-term benefits, limiting stent thrombosis, restenosis, neoatherosclerosis, constant vascular inflammation, and providing complete vascular restoration. Current guidelines, based on historical data on poly-L-lactide (PLLA) scaffolds, recommend the use of any bioresorbable scaffold, exclusively within controlled clinical trials (class III recommendation, evidence level C). Nevertheless, a metallic resorbable magnesium scaffold (RMS), Magmaris (Biotronik AG, Bulach, Switzerland), was launched on the market. Metallic and antithrombotic properties make this scaffold an attractive technology, its mechanical properties substantially differ from those of polymer-based scaffolds and the experience with previous procedures has shown that a standardized implantation technique and optimal patient and lesion selection are key factors for a successful implantation. Following the first consensus document on the use of this device, recently, a panel of expert Italian cardiologists published a second consensus document on the best practices for Magmaris implantation, in a selected patient population. The aim of this Special Issue is to highlight the benefits of this new technology and discuss new potential future indication in a global context.
Dr. Stefano Galli
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Resorbable magnesium scaffold
- Bioresorbable scaffolds
- Coronary artery lesions
- Neoatherosclerosis
- Restenosis
- Stent thrombosis
- Vascular restoration
